483 Roundup: Five Drugmakers Cited for Quality Failures By Sam | November 5, 2020 FDA investigators cited five drug facilities for failures ranging from late field reports to lax control of data, complaint handling and training. Source: Drug GMP Report Posted in Drug GMP Report